Further development may be significant for BML-260, which does not appear to have undergone any additional structural optimization since the initial publication by Cutshall et al (Cutshall et al, 2005 ).
← all excerpts
Modulating phosphatase DUSP22 with BML-260 ameliorates skeletal muscle wasting via Akt independent JNK-FOXO3a repression.
2
—
—
The sentences
Western blotting indicated that DUSP22 knockdown increased fast myosin (MYH2) mean expression, although it did not reach statistical significance (Fig. 3I,J ).